1. Home
  2. WAT vs ERIE Comparison

WAT vs ERIE Comparison

Compare WAT & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • ERIE
  • Stock Information
  • Founded
  • WAT 1958
  • ERIE 1925
  • Country
  • WAT United States
  • ERIE United States
  • Employees
  • WAT N/A
  • ERIE N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • ERIE Specialty Insurers
  • Sector
  • WAT Industrials
  • ERIE Finance
  • Exchange
  • WAT Nasdaq
  • ERIE Nasdaq
  • Market Cap
  • WAT 17.4B
  • ERIE 19.2B
  • IPO Year
  • WAT 1995
  • ERIE 1995
  • Fundamental
  • Price
  • WAT $382.16
  • ERIE $288.43
  • Analyst Decision
  • WAT Buy
  • ERIE
  • Analyst Count
  • WAT 13
  • ERIE 0
  • Target Price
  • WAT $379.00
  • ERIE N/A
  • AVG Volume (30 Days)
  • WAT 652.9K
  • ERIE 162.1K
  • Earning Date
  • WAT 11-04-2025
  • ERIE 10-30-2025
  • Dividend Yield
  • WAT N/A
  • ERIE 1.91%
  • EPS Growth
  • WAT 3.82
  • ERIE 15.90
  • EPS
  • WAT 10.88
  • ERIE 12.39
  • Revenue
  • WAT $3,105,638,000.00
  • ERIE $4,040,325,000.00
  • Revenue This Year
  • WAT $7.12
  • ERIE $10.96
  • Revenue Next Year
  • WAT $6.22
  • ERIE $8.12
  • P/E Ratio
  • WAT $34.88
  • ERIE $23.13
  • Revenue Growth
  • WAT 6.90
  • ERIE 9.53
  • 52 Week Low
  • WAT $275.05
  • ERIE $276.91
  • 52 Week High
  • WAT $423.56
  • ERIE $456.93
  • Technical
  • Relative Strength Index (RSI)
  • WAT 69.65
  • ERIE 39.02
  • Support Level
  • WAT $340.09
  • ERIE $276.91
  • Resistance Level
  • WAT $391.79
  • ERIE $290.88
  • Average True Range (ATR)
  • WAT 10.91
  • ERIE 10.40
  • MACD
  • WAT 1.20
  • ERIE -0.65
  • Stochastic Oscillator
  • WAT 80.12
  • ERIE 18.87

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

Share on Social Networks: